Adicet Bio
ACET
$1.68
Share price
-7.18%
Change (1 day)
-71.53%
Change (1 year)
Categories
Adicet Bio (ACET) - Cash on Hand
Cash on Hand as of December 2023 : $0.15 B
According to Adicet Bio's latest financial reports the company has $0.15 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Adicet Bio - Cash on Hand chart (from 2019 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-12-31 | $0.25 B | -7.17% |
| 2021-12-31 | $0.27 B | 193.34% |
| 2020-12-31 | $94.61 M | 51.63% |
| 2019-12-31 | $62.4 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Novartis NVS | $13.96 B | 8,642.04% | 🇨🇭 Switzerland |
 Pfizer PFE | $12.69 B | 7,845.60% | 🇺🇸 USA |
 Merck MRK | $7.09 B | 4,341.15% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | $3.22 B | 1,919.90% | 🇮🇱 Israel |
 Hawkins HWKN | $5.74 M | -96.41% | 🇺🇸 USA |
 Quaker Houghton KWR | $0.19 B | 21.80% | 🇺🇸 USA |